Esophageal adenocarcinoma relapse after chemoradiation is dominated by a basal-like subtype
Sascha Hoppe(University of Cologne), Axel M. Hillmer(University of Cologne)
Cited by 0
Related Papers
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC
|Journal of Thoracic Oncology|2023|24